Ko et al., 1998 - Google Patents
TGF-β1 effects on proliferation of rat intestinal epithelial cells are due to inhibition of cyclin D1 expressionKo et al., 1998
View PDF- Document ID
- 583486905197806501
- Author
- Ko T
- Yu W
- Sakai T
- Sheng H
- Shao J
- Beauchamp R
- Thompson E
- Publication year
- Publication venue
- Oncogene
External Links
Snippet
Transforming growth factor-beta 1 (TGF-β1) arrests intestinal epithelial cells (RIE-1 and IEC- 6) in the G1 phase of the cell cycle and inhibits cyclin D1 expression. This report describes experiments designed to elucidate the mechanism of cyclin D1 inhibition and to determine …
- 102000006311 Cyclin D1 0 title abstract description 138
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ko et al. | TGF-β1 effects on proliferation of rat intestinal epithelial cells are due to inhibition of cyclin D1 expression | |
| US6617171B2 (en) | Methods for diagnosing and treating autoimmune disease | |
| Waters et al. | Insulin-stimulated disassociation of the SOS-Grb2 complex | |
| Rodriguez-Viciana et al. | Phosphatidylinositol 3’kinase: one of the effectors of Ras | |
| Clevenger | Role of prolactin/prolactin receptor signaling in human breast cancer | |
| US20050233991A1 (en) | Methods and compositions for the identification, assessment, and therapy of small cell lung cancer | |
| US20060035849A1 (en) | Methods and composition for modulating type I muscle formation using pgc-1 alpha | |
| Braun et al. | Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation | |
| JP2009527485A (en) | Regulation of bone formation | |
| JP2003512304A (en) | Pharmaceutical composition and method using secretory frizzling-related protein | |
| US11291706B2 (en) | Methods for identification, assessment, prevention, and treatment of metabolic disorders using Slit2 | |
| Rehnmark et al. | Differential adrenergic regulation of C/EBPα and C/EBPβ in brown adipose tissue | |
| Dai et al. | Rcho-1 trophoblast cell placental lactogens: complementary deoxyribonucleic acids, heterologous expression, and biological activities | |
| US10429384B2 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders | |
| Jolivet et al. | Regulation by the extracellular matrix (ECM) of prolactin‐induced αs1‐casein gene expression in rabbit primary mammary cells: Role of STAT5, C/EBP, and chromatin structure | |
| Ko et al. | A kinase-defective transforming growth factor-beta receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cells. | |
| US20080248475A1 (en) | Methods and Compositions for Modulating Gluconeogenesis Using PGC-1 | |
| EP0897425A1 (en) | Novel trio molecules and uses related thereto | |
| EP1226279A1 (en) | Modulation of neuroendocrine differentiation by protein 25.1 | |
| US20050084916A1 (en) | Identification of the IkappaBNS protein and its products | |
| WO2008033374A2 (en) | Ocl-2a3 compositions and uses thereof | |
| Liu | The role of CREM/ICER transcription factors in bone | |
| Crist et al. | EGR-1 Prevents growth arrest by induction of c-myc | |
| Beck Jr | The roles of the pRb and p300 families in osteoblast differentiation | |
| ROUSSET | Connexin32 acts as a down regulator of growth of thyroid gland |